Amgen and Dezima Pharma B.V. announced that the companies have entered into a definitive acquisition agreement under which Amgen will...
Teva Pharma UK has launched generic versions of Seroquel and Seroquel XL as Quetiapine and Quetiapine XL.Other generic versions are...
Starpharma announced that it completed the VivaGel BV treatment clinical section of the NDA clinical module.
Teva Pharmaceutical Industries Ltd. and Auspex Pharmaceuticals, Inc. announced that they have entered into a definitive merger agreement under which...
Starpharma has received marketing approval in the European Union for VivaGel BV for the treatment and rapid relief of bacterial...
This phase 1-2 study evaluated brentuximab vedotin (BV) combined with nivolumab (Nivo) as first salvage therapy in patients with relapsed/refractory (r/r) classical Hodgkin lymphoma (cHL).
The FDA has expanded the indication for Azilect (rasagiline tablets), from Teva Pharma, from monotherapy and adjunct to levodopa (LD)...
This systematic review and meta-analysis aimed to determine the effectiveness of brentuximab vedotin (BV) in relapsed/refractory classical Hodgkin lymphoma (R/R cHL) in the clinical practice setting using most recent results.
Alder BioPharmaceuticals, Inc.announced that it has entered into a European patent settlement and global license agreement with Teva Pharmaceuticals International...
MorphoSys AG announced that it has acquired all outstanding shares of the Dutch biopharmaceutical company Lanthio Pharma B.V. The transaction...